Artificial Leaf Acts as a Mini Medicine Factory
News Apr 25, 2018 | Original story from Eindhoven University of Technology
Even with the naked eye the amount of light captured by the 'mini-factories' is visible, lit up bright red. The 'veins' through the leaves are the thin channels through which liquid can be pumped. The start products enter the one channel, light causes the reactions and the end product comes out via the other channels. Credit: Bart van Overbeeke
Using sunlight for sustainable and cheap production of, for example, medicines. The 'mini-factory' in the form of a leaf that chemical engineers from Eindhoven University of Technology presented in 2016 showed that it is possible. Now the researchers have come with an improved version: their 'mini-factory' is now able to keep production at the same level, irrespective of the variation in sunlight due to cloudiness or time of the day. As a result, this boosts the average yield by about 20%. This is due to a clever feedback system costing less than 50 euros that automatically slows down or speeds up production. This has removed a significant practical barrier for green reactors that operate purely on sunlight.
With their ‘artificial leaf’ researchers, under the guidance of the Eindhoven chemical engineer Timothy Noël, reaped a lot of admiration about a year and a half ago. First they succeeded in making chemical reactions possible with sunlight - something that had previously seemed almost impossible. Chemists had dreamed of this possibility for ages, but the problem was that the amount of sunlight was not sufficient.
Learn more: Video interview with Dr. Tim Noël
Their breakthrough can be partly attributed to the use of relatively new materials (so-called luminescent solar concentrators) that seal in a specific part of the sunlight inside, in a similar way to plants that do this using special antenna molecules in their leaves. The second discovery was to apply very thin channels in these materials, through which liquids are pumped thereby exposing the liquids to sufficient sunlight to allow chemical reactions to take place. The end products then flow out at the extremities of the channels.
Problem: not always the same amount of sun
One of the biggest practical problems to apply this on a large scale is that there is not always the same intensity of sunlight. Because, for example, the sky is cloudy or the sunlight varies in intensity and composition during the day. "If there is too much light, you get unwanted by-products and if there is too little light, the reactions do not take place or do so too slowly," Noël explains. "Ideally, the system should automatically adapt to the amount of incoming sunlight."
The feedback system developed does exactly that. It consists of just three relatively simple elements. A light sensor measures the amount of light that reaches the channels. A microcontroller translates this signal to a pump speed. And the pump drives the fluids through the channels at that speed. All this costs less than 50 euros. Experiments to determine the required pump speed for a specific light intensity enabled the researchers to optimize the feedback loop.
Test on the roof
In addition to lab testing under artificial light, they also tested their system outdoors in natural sunlight, on top of the roof of one of the buildings on the TU/e campus. At a yield setting of 90%, the system kept production stable for an hour at between 86% and 93%. The same system without feedback looping varied significantly between 55% and 97%. The average yield was increased by about 20% thanks to the feedback loop.
According to Noël, this brings a cheap and sustainable reactor considerably closer to being able to produce chemical products on a large scale, wherever you want, with only sunlight as an energy source. "It is inevitable that energy prices will rise. And with a source of energy like the sun that is free and available, these kinds of technological solutions can make the difference."
Watch: Experts in Flow Chemistry explain what it can do for society
This article has been republished from materials provided by Eindhoven University of Technology. Note: material may have been edited for length and content. For further information, please contact the cited source.
Fang Zhao, Dario Cambié, Volker Hessel, Michael Debije and Timothy Noël, Real-time reaction control for solar production of chemicals under fluctuating irradiance, Green Chemistry 2018, 24 april 2018
An FDA-approved drug has been identified that, when used with surgery, hampers metastasis in an animal model. Originally developed and approved ~65 years ago to control blood pressure, the medication resperine also prevents what are known as tumor-derived extracellular vesicles from fusing to healthy cells and sharing their cargo of disease-promoting molecules.READ MORE
16th International Conference on Structural Biology
Mar 11 - Mar 12, 2019
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019